Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

By In The News
January 9, 2020 in The Headlines

Recommended Posts

In The News

Posted January 9, 2020

- Share

Posted January 9, 2020

BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- Almirall, S.A. (ALM) and WuXi Biologics ("WuXi Bio") (2269.HK) have today announced the signing of an agreement. Through this collaboration Almirall embarks on its strategy to develop highly innovative biologic products for dermatology...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219804
2. Jaydee
  16686
3. Kip Powick
  12206
4. deicer
  12176
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.1k
- Total Posts
  
  558.4k

Sign In

Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support